31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
Following the challenges to AB 5, California’s controversial new independent contractor law, can be...
Read More >
Germany’s cabinet has approved draft legislation designed to tighten the country’s foreign investm...
Read More >
As July 15th draws closer, EEOC and NORC are ramping up for opening of the EEO-1 Component 2 Pay Dat...
Read More >
In his 2016 presidential campaign, Donald Trump frequently expressed populist themes, rhetorically c...
Read More >
Legal System - 1. Is your jurisdiction primarily a common law, civil law, customary law or theocra...
Read More >
When is sleeping working? According to a recent DOL Opinion Letter, probably not when it occurs off ...
Read More >